The much awaited Indian tour of England was announced today. The Indian Cricket Board announced the entire schedule on Thursday. In February next year, a series of four Test matches, five T20s and three ODIs will be played between the two countries. Also read: Day-night Test match to be held at Motera Stadium in Ahmedabad, when Team India will take on the British
This long tour of England will begin with the Test match in Chennai from 5 February. The second match will also be played at this place. The third Test in Ahmedabad will be Day-Night, which will be played with Pink Ball. The fourth Test will also be headed by Motera Stadium in Ahmedabad, which is all set for its first match after reconstruction in early 2020.
In the current situation, the entire cricket program will be held in only three centers in view of the Quarantine Guidelines. Pune will host a three-match one-day series in addition to Chennai, Ahmedabad. This will be the first international cricket competition on the Indian soil after the Corona transition, before the South African team, which visited India in March, had to leave the tour and return home.
BCCI Secretary Jai Shah on Thursday announced Motera to host the day-night Test during the inauguration of the Indoor Academy of Gujarat Cricket Association. This will be the second match on the Indian side with the pink ball after the day-night Test against Bangladesh at Eden Gardens last year. A BCCI source said on the condition of confidentiality, ‘England’s team will not tour the entire country in the current situation (Covid-19 epidemic). There are only three cities where BCCI is creating a bio-safe environment (bio-bubble). Two Tests and five T20 Internationals will take place in Ahmedabad. The BCCI’s operating team, after much deliberation, found that these three sites are suitable for making bio-bubble for both these teams. The successful opening of England will open the door for the Indian Premier League to be held in the country. The previous season of IPL was played in the UAE due to Covid-19.